Annual Cash & Cash Equivalents
$248.40 M
+$43.52 M+21.24%
December 31, 2023
Summary
- As of February 7, 2025, BHVN annual cash & cash equivalents is $248.40 million, with the most recent change of +$43.52 million (+21.24%) on December 31, 2023.
- During the last 3 years, BHVN annual cash & cash equivalents has risen by +$165.90 million (+201.07%).
- BHVN annual cash & cash equivalents is now -21.57% below its all-time high of $316.73 million, reached on December 31, 2019.
Performance
BHVN Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$84.39 M
-$154.76 M-64.71%
September 30, 2024
Summary
- As of February 7, 2025, BHVN quarterly cash and cash equivalents is $84.39 million, with the most recent change of -$154.76 million (-64.71%) on September 30, 2024.
- Over the past year, BHVN quarterly cash and cash equivalents has dropped by -$164.01 million (-66.03%).
- BHVN quarterly cash and cash equivalents is now -81.88% below its all-time high of $465.74 million, reached on June 1, 2019.
Performance
BHVN Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
BHVN Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +21.2% | -66.0% |
| 3 y3 years | +201.1% | -58.8% |
| 5 y5 years | -6.0% | -58.8% |
BHVN Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +226.6% | -67.3% | +66.5% |
| 5 y | 5-year | -21.6% | +226.6% | -80.3% | +66.5% |
| alltime | all time | -21.6% | >+9999.0% | -81.9% | +258.1% |
Biohaven Pharmaceutical Holding Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $84.39 M(-64.7%) |
| Jun 2024 | - | $239.15 M(+30.9%) |
| Mar 2024 | - | $182.71 M(-26.4%) |
| Dec 2023 | $248.40 M(+21.2%) | $248.40 M(+122.4%) |
| Sep 2023 | - | $111.70 M(-24.3%) |
| Jun 2023 | - | $147.61 M(+18.1%) |
| Mar 2023 | - | $125.03 M(-39.0%) |
| Dec 2022 | $204.88 M(+169.4%) | $204.88 M(+304.4%) |
| Sep 2022 | - | $50.67 M(-80.3%) |
| Jun 2022 | - | $257.80 M(+239.0%) |
| Dec 2021 | $76.06 M(-7.8%) | - |
| Dec 2021 | - | $76.06 M(-42.4%) |
| Dec 2020 | $82.51 M(-74.0%) | - |
| Dec 2020 | - | $132.15 M(-58.2%) |
| Sep 2020 | - | $316.23 M(+21.1%) |
| Jun 2020 | - | $261.06 M(-39.0%) |
| Mar 2020 | - | $428.24 M |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $316.73 M(+19.9%) | - |
| Dec 2019 | - | $316.73 M(-24.0%) |
| Sep 2019 | - | $416.57 M(-10.6%) |
| Jun 2019 | - | $465.74 M(+114.2%) |
| Mar 2019 | - | $217.41 M(-17.7%) |
| Dec 2018 | $264.25 M(+101.0%) | - |
| Dec 2018 | - | $264.25 M(+57.1%) |
| Sep 2018 | - | $168.19 M(-22.7%) |
| Jun 2018 | - | $217.45 M(+108.7%) |
| Mar 2018 | - | $104.21 M(-20.7%) |
| Dec 2017 | $131.47 M(+457.9%) | - |
| Dec 2017 | - | $131.47 M(-25.2%) |
| Sep 2017 | - | $175.75 M(-14.0%) |
| Jun 2017 | - | $204.29 M(+290.7%) |
| Mar 2017 | - | $52.29 M(+121.9%) |
| Dec 2016 | $23.57 M(+1514.0%) | - |
| Dec 2016 | - | $23.57 M |
| Dec 2015 | $1.46 M | - |
FAQ
- What is Biohaven Pharmaceutical Holding annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Biohaven Pharmaceutical Holding?
- What is Biohaven Pharmaceutical Holding annual cash & cash equivalents year-on-year change?
- What is Biohaven Pharmaceutical Holding quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Biohaven Pharmaceutical Holding?
- What is Biohaven Pharmaceutical Holding quarterly cash and cash equivalents year-on-year change?
What is Biohaven Pharmaceutical Holding annual cash & cash equivalents?
The current annual cash & cash equivalents of BHVN is $248.40 M
What is the all time high annual cash & cash equivalents for Biohaven Pharmaceutical Holding?
Biohaven Pharmaceutical Holding all-time high annual cash & cash equivalents is $316.73 M
What is Biohaven Pharmaceutical Holding annual cash & cash equivalents year-on-year change?
Over the past year, BHVN annual cash & cash equivalents has changed by +$43.52 M (+21.24%)
What is Biohaven Pharmaceutical Holding quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of BHVN is $84.39 M
What is the all time high quarterly cash and cash equivalents for Biohaven Pharmaceutical Holding?
Biohaven Pharmaceutical Holding all-time high quarterly cash and cash equivalents is $465.74 M
What is Biohaven Pharmaceutical Holding quarterly cash and cash equivalents year-on-year change?
Over the past year, BHVN quarterly cash and cash equivalents has changed by -$164.01 M (-66.03%)